Essilor eyes new generation of spectacle lens solutions to curb myopia

 KUALA LUMPUR, Oct 6 -- Essilor, the world’s leading ophthalmic optics company, recently launched Stellest™ lens, a new generation of spectacle lens solutions in the fight against myopia.

In line with its mission to improve lives by improving sight and commitment to focus resources where they are most needed, Essilor launched the lens in the Wenzhou Medical University Eye Hospital in China last July.

According to a statement, this will be followed by a broader roll-out across other hospitals and top stores of selected chains in China, and progressively by several other countries.

Together with its key partner, the Wenzhou Medical University, Essilor launched in 2018 a three-year clinical trial on 167 myopic children in their joint Research and Development Center in China.

The one-year results already demonstrate strong evidence of the Stellest™ lens’ effectiveness in slowing down myopia progression, positioning it as Essilor’s best solution to fight myopia progression in children.

Indeed, the children wearing Stellest™ lenses saved over half a diopter of myopia degree on average, corresponding to over 60 per cent slow-down in myopia progression on average, when compared to the control group wearing single vision lenses.

Equally, over the same period, eye elongation was prevented in 28 per cent of the children wearing Stellest™ lenses, while it occurred in all the children wearing single vision lenses.

The Stellest™ lens has been designed by Essilor’s industry-leading research and development teams with an exclusive, pioneering technology called Highly Aspherical Lenslet Target.

-- BERNAMA